Pure Global

20.0 mg/ml sterile viscoelastic sodium hyaluronate gel for intra-articular injection - India CDSCO Medical Device Registration

20.0 mg/ml sterile viscoelastic sodium hyaluronate gel for intra-articular injection is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000358_c5eda7a13dbd92b86b9229f2837b18cb_d666155010ecceaca7d4ed2ac8e4a2f0. This device is marketed under the brand name Hylasto-S. The license holder is Zydus Healthcare Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
20.0 mg/ml sterile viscoelastic sodium hyaluronate gel for intra-articular injection
UID: IMP/MD/2018/000358_c5eda7a13dbd92b86b9229f2837b18cb_d666155010ecceaca7d4ed2ac8e4a2f0

Brand Name

Hylasto-S

Device Class

Class D

Approving Authority

CDSCO

Product Information

The viscoelastic solution is designed to be injected intra-articularly (Hylasto-S) as viscosupplementation in the treatment of osteoarthritis. It is indicated to reduce pain and restricted mobility due to degenerative and traumatic changes in synovial joints.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Other Products from Zydus Healthcare Limited
Products from the same license holder (1 products)